Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-20
1998-05-05
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 514314, 514336, 514340, 514342, 514344, 514345, 514351, 514438, 514441, 514444, 514445, 514461, 514471, 514473, 546146, 546148, 546152, 546175, 546176, 546250, 546256, 546261, 546265, C07D21512, C07D21712, C07D40912, A61K 3147
Patent
active
057475059
ABSTRACT:
The heterocyclic aryl-, alkyl- and cycloalklacetamides are prepared by reacting the appropriately substituted acetic acids with amines, if appropriate in complexed form. The heterocyclic aryl-, alkyl- and cycloalkylacetamides can be used as active compounds in medicaments, in particular in antiatherosclerotic medicaments.
REFERENCES:
patent: 4248788 (1981-02-01), Bourgery et al.
patent: 4970215 (1990-11-01), Mohrs et al.
patent: 5310744 (1994-05-01), Raddatz et al.
patent: 5352687 (1994-10-01), Muller et al.
patent: 5420149 (1995-05-01), Muller et al.
patent: 5521206 (1996-05-01), Muller et al.
patent: 5527809 (1996-06-01), Muller-Gliemann et al.
R. Stauffer: Synthese de nouvelles tryptamines substituees, Helvetica Chimica Acta, Bd. 49, Nr. 3, 1966, 1199-1203.
J.C. Gaignault et al: Indolylmethyl-1 tetrahydro-1,2,3,4-isoquinoleines et benzyl-1 tetrahydro2,3,4,9/1H/beta-carbolines formees a partir de la tryptamine et de ses derives, Annales Pharmaceutiques Francaises, Bd. 36, Nr. 9-10, 1978, 401-408.
Bodanszky, The Practice of Peptide Synthesis: Springer Verlag, vol. 21, 1984, 1984, pp. VIII-XVII.
Organic Chemistry; Functional Group Transformations: Academic Press, vol. 12-1 (1983).
J. Org. Chem., 1968, 33, 2902.
Beuck Martin
Bischoff Hilmar
Connell Richard
Denzer Dirk
Goldmann Siegfried
Bayer Aktiengesellschaft
Oswecki Jane C.
Richter Johann
LandOfFree
Heterocyclic aryl-, alkyl- and cycloalkylacetamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic aryl-, alkyl- and cycloalkylacetamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic aryl-, alkyl- and cycloalkylacetamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55026